Retrospective comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as second-line treatment for advanced gastric cancer focusing on peritoneal metastasis

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram et al. · CA A Cancer Journal for Clinicians · 2018 · 87.7K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial

H. Wilke, Kei Muro, Eric Van Cutsem et al. · The Lancet Oncology · 2014 · 2.5K citations

Medicine, Oncology, Pharmacotherapy +13

Endothelial Cell-Surface Gp60 Activates Vesicle Formation and Trafficking via Gi-Coupled <i>Src</i> Kinase Signaling Pathway

Richard D. Minshall, Chinnaswamy Tiruppathì, Stephen M. Vogel et al. · The Journal of Cell Biology · 2000 · 290 citations · Full text

Life Sciences, Biochemistry, Cell Biology +17

Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial

Kohei Shitara, Atsuo Takashima, Kazumasa Fujitani et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 219 citations

Medicine, Oncology, Pharmacology +7

gp60 is an albumin-binding glycoprotein expressed by continuous endothelium involved in albumin transcytosis

Jan E. Schnitzer · American Journal of Physiology-Heart and Circulatory Physiology · 1992 · 219 citations

Life Sciences, Biochemistry, Cell Biology +7